Since it came onto the market in 1983, glyburide has been one of the most popular sulfonylureas. The American Diabetes Association (ADA) recommends the use of these agents as part of a stepwise approach to treating type 2 diabetes mellitus.
Maegan Rogers, PharmD
Advertisement
Articles by Maegan Rogers, PharmD
Advertisement
Latest Updated Articles
- Sulfonylurea-Induced Hypoglycemia: The Case Against Glyburide
Published: February 18th 2011 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
WHO: 1 in 6 Common Infections Now Drug-Resistant, AMR Threatens Global Health
2
FDA Clears First Blood Test to Rule Out Alzheimer-Related Pathology in Primary Care
3
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
4
Post-MI Psychological Distress: Contributing Factor To and Consequence of Cardiovascular Disease
5
